Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

DrMedHealth vs Queen RX

DrMedHealth
Graded #198

Higher grade

vs+0.20000000000000284
Queen RX
Graded #214

Lower grade

The verdict

DrMedHealth takes it — 66.2/100 to 66/100, but only just.

DrMedHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. DrMedHealth is a LegitScript-certified US telehealth platform for GLP-1 medical weight loss. Queen RX is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueQueen RX +22
54
76
Dose & formulationDrMedHealth +20
77
57
Clinical oversightDrMedHealth +13
82
69
Labs & monitoringEven
53
53
FulfillmentQueen RX +4
71
75
Contract termsQueen RX +6
55
61
DrMedHealth · left barQueen RX · right bar

The numbers

MetricDrMedHealthQueen RX
WeighScore66.2/10066/100
GradeCC
Scorecard rank#198#214
Semaglutide$199/mo (starting dose, compounded)$100/mo (quarterly plan, compounded)
Tirzepatide$299/mo (starting dose, compounded)Not disclosed
CoverageCoverage not published45 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
DrMedHealth

Graded #198 · C

Strengths

  • LegitScript certified telehealth platform
  • Low compounded pricing: semaglutide from $199/mo, tirzepatide from $299/mo
  • Both compounded and FDA-approved branded options available
  • Fast physician review (advertised ~2 hours) with free shipping
  • Compounded by licensed US pharmacies

Where it loses points

  • Compounded GLP-1s are not FDA-approved for safety, efficacy or quality
  • Cash-pay model; insurance generally not accepted for medication
  • Full list of available states not consolidated in one place
  • Site is JavaScript-rendered, limiting easy review of full terms
Queen RX

Graded #214 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard